| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Influenza A (H1N1) 2009 Pandemic Monovalent Vaccine (Without Adjuvant) 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus Victoria and Yamagata lineage standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf AGRIFLU SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| FLUZONE Quadrivalent 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| HAHB Hepatitis A + B regular strength unspecified |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| VAQTA 50 units per milliliter suspension for injection Merck Canada Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Inf AFLURIA TETRA SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Adult vaccine product containing only Hepatitis A virus regular strength antigen (medicinal product) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFLUVAC 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Inf FLUAD SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| FLUVIRAL 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Intanza 9 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Inf AFLURIA TETRA SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf AGRIFLU SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf AGRIFLU SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Intanza 9 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Havrix 1440 ELISA units per milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Intanza 9 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Inf FLUAD SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Xanaflu 15 micrograms per 0.5 milliliter suspension for injection Drug Safety, Abbott Laboratories, Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf FLUAD SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf AFLURIA TETRA SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Inf AFLURIA TETRA SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Inf INFLUVAC BGP |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Adjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Agriflu 15 micrograms per 0.5 milliliter suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf INFLUVAC BGP |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Intanza 15 micrograms per 0.1 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Engerix B 20 micrograms per milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| AVAXIM 160 units per 0.5 milliliter suspension for injection Sanofi Pasteur Limited (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Vaxigrip 15 micrograms per 0.5 milliliter suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Agriflu 15 micrograms per 0.5 milliliter suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Agriflu 15 micrograms per 0.5 milliliter suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLUAD 15 micrograms per 0.5 milliliter suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Epaxal Berna 500 radioimmunoassay units per 0.5 milliliter suspension for injection Swiss Serum and Vaccine Institute Berne (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| RECOMBIVAX HB 10 micrograms per milliliter suspension for injection Merck Canada Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Adult vaccine product containing only Hepatitis B virus regular strength antigen (medicinal product) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| Inf INFLUVAC BGP |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| HA EPAXAL BB |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Twinrix 720 ELISA units HAV and 20 micrograms HBV per milliliter suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| FLUAD 15 micrograms per 0.5 milliliter suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLUAD 15 micrograms per 0.5 milliliter suspension for injection Novartis Vaccines and Diagnostics, Inc. (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| FLUZONE suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLUZONE suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| FLUZONE suspension for injection Sanofi Pasteur SA (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf FLUCELVAX QUAD SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| Inf FLUCELVAX QUAD SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| Inf FLUCELVAX QUAD SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Inf FLUCELVAX QUAD SEQ |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| INFLUSPLIT TETRA 15 micrograms per 0.5 milliliter suspension for injection GlaxoSmithKline Biologicals (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| INFLUVAC TETRA 15 micrograms per 0.5 milliliter suspension for injection BGP Pharma ULC (real clinical drug) |
Has ingredient characteristic (attribute) |
False |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| Pediatric vaccine product containing only diptheria standard dose + pertussis standard dose + tetanus + hepatitis B antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| DPT Adsorbed suspension for injection Aventis Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DPT Adsorbed suspension for injection Aventis Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Adult vaccine product containing only Hepatitis A virus regular strength antigen (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| PEDIARIX suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Pediatric vaccine product containing only diptheria standard dose + pertussis standard dose + tetanus + hepatitis B antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| Unadjuvanted vaccine product containing only Influenza A virus subtypes H1N1 and H3N2 and Influenza B virus standard dose each non-live antigen in parenteral dose form (medicinal product form) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| PEDIARIX suspension for injection GlaxoSmithKline Inc. (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + inactivated poliovirus + Haemophilus influenza type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| DPT Polio Adsorbed suspension for injection Aventis Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
4 |
| Pediatric vaccine product containing only diptheria standard dose + pertussis standard dose + tetanus + hepatitis B + Haemophilus influenzae type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| DPT Polio Adsorbed suspension for injection Aventis Pasteur Limited (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
1 |
| Pediatric vaccine product containing only diphtheria standard dose + pertussis standard dose + tetanus + inactivated poliovirus + Haemophilus influenza type b antigens (medicinal product) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
3 |
| FLULAVAL TETRA 15 micrograms per 0.5 milliliter suspension for injection ID Biomedical Corporation of Quebec (real clinical drug) |
Has ingredient qualitative strength |
True |
Standard dose (qualifier value) |
Inferred relationship |
Some |
2 |
FHIR